Related Experiment Video
Updated: Aug 7, 2026
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
The molecular mechanisms of vascular restenosis: Which genes are crucial?
Jemma Bhoday1, Sampath de Silva, Qingbo Xu
1Department of Cardiac and Vascular Sciences, St. George's University of London, London, UK.
Abstract:
Many patients with coronary heart disease undergo percutaneous transluminal coronary angioplasty (PTCA) to improve myocardial tissue perfusion. However, a major complication after revascularisation procedures is restenosis of the injured artery. The molecular mechanism involved is not fully elucidated and no successful treatment is currently available. Animal models are preliminary tools that can help improve our understanding of the pathogenesis and treatment of restenosis in humans. Attracted by well-defined genetic systems, a number of investigators began to use the mouse as an experimental system for restenosis research. They demonstrated that several stages involved in this process include thrombus formation, inflammatory cell infiltration and smooth muscle cell (SMC) accumulation to form neointimal lesions. By using transgenic and knockout mice a number of genes related to these processes have been found to play a major role in mediating lesion formation, e.g. the plasminogen system, matrix metalloproteinases (MMP), adhesion molecules, cytokines and signal transducers. This review will not attempt to cover all aspects of related genes or molecules, but will rather focus on several groups of genes, by which the major progress in understanding the mechanisms of the disease has been made. The information obtained by using animal models could be essential for a better understanding of the pathogenesis of restenosis in humans and to provide a basis for therapeutic intervention.
Insights
Mouse models reveal key genes and pathways involved in arterial restenosis after angioplasty. Understanding these molecular mechanisms is crucial for developing effective treatments for this common complication.
Area of Science:
- Cardiovascular Biology
- Translational Medicine
- Molecular Genetics
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) can lead to arterial restenosis, a significant complication with unclear molecular mechanisms.
- Current treatments for restenosis are limited, necessitating further research into its pathogenesis.
Purpose of the Study:
- To review the role of animal models, particularly mice, in elucidating the molecular mechanisms of restenosis.
- To highlight key genes and molecular pathways implicated in neointimal lesion formation after arterial injury.
Main Methods:
- Utilizing genetically modified mouse models (transgenic and knockout) to study restenosis.
- Analyzing the involvement of specific gene families including the plasminogen system, matrix metalloproteinases (MMPs), adhesion molecules, cytokines, and signal transducers.
Main Results:
- Mouse models recapitulate key stages of restenosis: thrombus formation, inflammatory cell infiltration, and smooth muscle cell accumulation.
- Genetic studies in mice have identified critical genes that mediate neointimal lesion development.
Conclusions:
- Animal models provide essential insights into the pathogenesis of human restenosis.
- Understanding the molecular basis of restenosis through these models is vital for developing future therapeutic strategies.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
01:10Mechanism of Angiogenesis